Ginecologia/Obstetrícia

M-A | Desfechos do tratamento de gestantes com tuberculose multirresistente.

19 Jun, 2022 | 15:18h

Treatment Outcomes Among Pregnant Patients With Multidrug-Resistant Tuberculosis: A Systematic Review and Meta-analysis – JAMA Network Open

 

Comentário no Twitter

This meta-analysis of pregnant patients treated for multi-drug-resistant tuberculosis (MDR-TB) found 73% treatment success and 73% favorable pregnancy outcomes, with adverse events (incl liver/kidney impairment, hearing loss) in more than half of patients. https://t.co/Mx5RLiwhU9

— JAMA Network Open (@JAMANetworkOpen) June 10, 2022

 

---

Breve resumo dos principais fatos atuais e recomendações | Linfadenopatia regional após vacinação contra COVID-19 em pacientes com ou sem suspeita de câncer de mama.

19 Jun, 2022 | 14:21h

Regional Lymphadenopathy Following COVID-19 Vaccination in Patients with or Suspicious of Breast Cancer: A Quick Summary of Current Key Facts and Recommendations – Korean Journal of Radiology

Conteúdos relacionados:

2 Case Series and Guidance | Lymphadenopathy in COVID-19 Vaccine Recipients

Axillary lymphadenopathy at the time of COVID-19 vaccination: ten recommendations from the European Society of Breast Imaging (EUSOBI) – Insights into Imaging

Covid-19: Schedule breast screening before vaccine or 4 to 6 weeks after to avoid false positives, says guidance – The BMJ

Frequency and outcomes of MRI-detected axillary adenopathy following COVID-19 vaccination – European Radiology

Regional lymphadenopathy following COVID-19 vaccination: Literature review and considerations for patient management in breast cancer care – European Journal of Cancer

---

Diretriz ESMO | Diagnóstico, tratamento e seguimento do câncer endometrial.

19 Jun, 2022 | 13:27h

Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up – Annals of Oncology

---

Análise de especialista | Tratamento da pericardite na gestação.

19 Jun, 2022 | 13:13h

Pericarditis Management in Pregnancy – American College of Cardiology

---

DNA circulante de tumor e recorrência tardia em câncer de mama de alto risco, positivo para receptor de hormônio e negativo para receptor do fator de crescimento epidérmico humano 2.

19 Jun, 2022 | 13:04h

Circulating Tumor DNA and Late Recurrence in High-Risk Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer – Journal of Clinical Oncology

Editorial: Can a Late Interception by Circulating Tumor DNA Deliver a Win in Estrogen Receptor–Positive Early Breast Cancer?

Comentário: Tumor DNA Assay Portends Metastatic Breast Cancer Recurrence Months in Advance — First evidence for patients in late adjuvant setting, years after initial diagnosis – MedPage Today (necessário cadastro gratuito)

 

Comentário no Twitter

103 women in long-term remission from high-risk HR+/HER2- breast cancer had customized monitoring of recurrence based on ctDNA seq for tumour-associated mut. Among 8 pts MRD+ pts, 6 developed distant recurrence at a median 12.4 mo after ctDNA positivity https://t.co/aX1ruLCSbb

— NatureRevClinOncol (@NatRevClinOncol) June 9, 2022

 

---

Estudo de coorte | Desfechos de neurodesenvolvimento em 1 ano em bebês de mães com teste positivo para SARS-CoV-2 durante a gestação.

16 Jun, 2022 | 13:58h

Neurodevelopmental Outcomes at 1 Year in Infants of Mothers Who Tested Positive for SARS-CoV-2 During Pregnancy – JAMA Network Open

Comentários:

Is It Exposure to the Pandemic or to Maternal SARS-CoV-2 Infection That Is Adversely Affecting Early Childhood Neurodevelopment? – JAMA Network Open

Expert reaction to observational study of mothers who tested positive for SARS-CoV-2 during pregnancy and neurodevelopmental outcomes in their children at 1 year – Science Media Centre

 

Comentário no Twitter

This cohort study of #SARSCoV2 exposure in utero found preliminary evidence that maternal SARS-CoV-2 may be associated with neurodevelopmental sequelae in some offspring. https://t.co/dYdoJbNOdl

— JAMA Network Open (@JAMANetworkOpen) June 9, 2022

 

---

Revisão sistemática | Intervenções educacionais para melhorar a saúde menstrual de adolescentes.

16 Jun, 2022 | 13:33h

Systematic review of educational interventions to improve the menstrual health of young adolescent girls – BMJ Open

---

[Comunicado de imprensa – ainda não publicado] Médicos alertam que as mulheres não estão sendo informadas de que um anestésico comum pode reduzir a efetividade dos anticoncepcionais.

16 Jun, 2022 | 13:08h

Women not being routinely informed that a common anesthetic may lessen contraception effectiveness, doctors warn – The European Society of Anaesthesiology and Intensive Care (ESAIC)

Comentário: Women in UK ‘seldom’ told drug used in surgery can impede contraception – The Guardian

---

Estudo confirma que o rastreamento a cada 5 anos é seguro para mulheres com teste negativo para HPV.

16 Jun, 2022 | 13:06h

Comunicado de imprensa: Screening every five years safe for women who test negative for HPV, study confirms – King’s College London

Estudo original: Extension of cervical screening intervals with primary human papillomavirus testing: observational study of English screening pilot data – The BMJ

Editorial: HPV screening for cervical cancer is reaching maturity – The BMJ

Diretriz OMS relacionada:

Comunicado de imprensa: New recommendations for screening and treatment to prevent cervical cancer – World Health Organization

Ver diretriz: WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention – World Health Organization

Diretriz USPSTF relacionada: Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement – JAMA

---

História de enxaqueca está associada a maior risco de desfechos gestacionais adversos.

16 Jun, 2022 | 12:55h

Migraine History Tied to Higher Risk for Adverse Pregnancy Outcomes – HealthDay

Estudo original: Migraine and adverse pregnancy outcomes: the Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be – American Journal of Obstetrics & Gynecology

---